The use of nonsteroidal anti-inflammatory drugs (NSAIDs) - A science advisory from the American Heart Association

被引:54
作者
Bennett, JS [1 ]
Daugherty, A [1 ]
Herrington, D [1 ]
Greenland, P [1 ]
Roberts, H [1 ]
Taubert, KA [1 ]
机构
[1] Amer Heart Assoc, Dallas, TX 75231 USA
关键词
AHA Science Advisory; anti-inflammatory agents; nonsteroidal; cyclooxygenase inhibitors; risk factors; aspirin;
D O I
10.1161/01.CIR.0000160005.90598.41
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Current evidence indicates that selective COX-2 inhibitors have important adverse cardiovascular effects including increased risk for myocardial infarction, stroke, heart failure, and hypertension. The risk for these adverse effects are likely greatest in patients with a prior history of, or at high risk for cardiovascular disease. In these patients, use of COX-2 inhibitors for pain relief should be limited to patients for whom there are no appropriate alternatives; and then, only in the lowest dose and for the shortest duration necessary. More long-term data are needed to fully evaluate the extent to which these important adverse cardiovascular effects may be offset by other beneficial effects of these medications. More data are also needed concerning the cardiovascular safety of conventional NSAIDs. Until such data are available, the use of any COX inhibitor, including over-the-counter NSAIDs, for long periods of time should only be considered in consultation with a physician.
引用
收藏
页码:1713 / 1716
页数:4
相关论文
共 18 条
[1]   Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis [J].
Bea, F ;
Blessing, E ;
Bennett, BJ ;
Kuo, CC ;
Campbell, LA ;
Kreuzer, J ;
Rosenfeld, ME .
CARDIOVASCULAR RESEARCH, 2003, 60 (01) :198-204
[2]   Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis [J].
Belton, OA ;
Duffy, A ;
Toomey, S ;
Fitzgerald, DJ .
CIRCULATION, 2003, 108 (24) :3017-3023
[3]  
Bresalier R.S., 2005, NEW ENGL J MED, P352
[4]   ARTERIAL-WALLS GENERATE FROM PROSTAGLANDIN ENDOPEROXIDES A SUBSTANCE (PROSTAGLANDIN-X) WHICH RELAXES STRIPS OF MESENTERIC AND CELIAC ARTERIES AND INHIBITS PLATELET-AGGREGATION [J].
BUNTING, S ;
GRYGLEWSKI, R ;
MONCADA, S ;
VANE, JR .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1976, 12 (06) :897-913
[5]   Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice [J].
Burleigh, ME ;
Babaev, VR ;
Oates, JA ;
Harris, RC ;
Gautam, S ;
Riendeau, D ;
Marnett, LJ ;
Morrow, JD ;
Fazio, S ;
Linton, MF .
CIRCULATION, 2002, 105 (15) :1816-1823
[6]   Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. [J].
Catella-Lawson, F ;
Reilly, MP ;
Kapoor, SC ;
Cucchiara, AJ ;
DeMarco, S ;
Tournier, B ;
Vyas, SN ;
FitzGerald, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) :1809-1817
[7]   Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen [J].
Chan, FKL ;
Chung, SCS ;
Suen, BY ;
Lee, YT ;
Leung, WK ;
Leung, VKS ;
Wu, JCY ;
Lau, JYW ;
Hui, Y ;
Lai, MS ;
Chan, HLY ;
Sung, JJY .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (13) :967-973
[8]   Cyclooxygenases, thromboxane, and atherosclerosis -: Plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism [J].
Egan, KM ;
Wang, M ;
Lucitt, MB ;
Zukas, AM ;
Puré, E ;
Lawson, JA ;
FitzGerald, GA .
CIRCULATION, 2005, 111 (03) :334-342
[9]   INCREASED PROSTACYCLIN BIOSYNTHESIS IN PATIENTS WITH SEVERE ATHEROSCLEROSIS AND PLATELET ACTIVATION [J].
FITZGERALD, GA ;
SMITH, B ;
PEDERSEN, AK ;
BRASH, AR .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (17) :1065-1068
[10]   Coxibs and cardiovascular disease [J].
FitzGerald, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) :1709-1711